Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn

Clean-tech company Superdielectrics relocates to Chesterford Research Park

The sustainable electrical energy storage specialist secures Suite 2 in the Science Village

Cambridge, UK, 15 February 2021: Chesterford Research Park is delighted to welcome material research company Superdielectrics to the Park’s prestigious Science Village.

Superdielectrics is developing high energy density, low cost, low environmental impact electrical energy storage devices that will help create a clean and sustainable global energy and transportation system. Supercapacitors store energy using electrodes and electrolytes and both charge and deliver energy quickly, unlike conventional batteries which perform the same task in a much slower way with the added hazard of end-of-life waste. Superdielectrics’ supercapacitors are safe, fast, contain no rare materials or conflict metals and have the added benefit of reducing pollution and waste.

Superdielectrics join fellow Science Village occupiers including Diagnostics for the Real World, Camena Bioscience and Oxford Nanopore in this energy-efficient, high-quality building, so stimulating company is guaranteed.

Jim Heathcote, CEO, Superdielectrics said: “Superdielectrics Ltd is delighted to have taken research and development laboratories at Chesterford Research Park. We are developing a completely clean and sustainable energy system using our unique high energy density supercapacitor materials.

“We are driven by strong environmental and social values which are shared by Chesterford Research Park. These are exciting times as we strive to tackle fundamental scientific problems that could reduce global poverty and starvation while cleaning up the environment.”

Chesterford Research Park provides an innovative and future-proofed environment for both established and early-stage biotechnology and pharmaceutical research and development companies. In addition to Superdielectrics, the Park is home to technology and life science innovators including Arecor, AstraZeneca, Lonza, Charles River Laboratories, Cambridge Epigenetix, Domainex and Oncologica.

Julian Cobourne, Senior Asset Manager, Aviva Investors, joint owners of Chesterford Research Park with Uttlesford District Council added: “I am thrilled that the innovative team at Superdielectrics will be continuing their ground-breaking work at Chesterford Research Park. With its focus on sustainability and the environment, Superdielectrics’ aims are complementary to that of the Park.

“Integral to the Cambridge biotech cluster, Chesterford Research Park continues to attract leading bioscience ventures. The fitted nature of the Science Village remains extremely popular with companies seeking ‘plug and play’ facilities, which negates the requirement for a protracted and sometimes expensive fit-out process. Superdielectrics are in good company in this truly unique setting with stunning natural parkland surroundings.”